Surrozen Presents Data on Lead Therapeutic Candidates at Digestive Disease Week (DDW)
SOUTH SAN FRANCISCO, Calif., May 24, 2022 (GLOBE NEWSWIRE) -- Surrozen, Inc. (Nasdaq: SRZN), a company pioneering…
Read More...
Read More...
Browsing Tag
DDW
DDW: Antibiotics Up Risk of Older-Onset Inflammatory Bowel Disease
Physician’s Briefing Staff
FRIDAY, May 13, 2022 (HealthDay News) -- Use of…
Read More...
Read More...
DDW: Gallstone Disease May Predict Pancreatic Cancer Incidence
Physician’s Briefing Staff
FRIDAY, May 13, 2022 (HealthDay News) -- In the year…
Read More...
Read More...
DDW: ‘Alarming’ Rise in Esophageal Cancer, Barrett Esophagus Seen in Middle-Age
Physician’s Briefing Staff
FRIDAY, May 13, 2022 (HealthDay News) -- While the…
Read More...
Read More...
Ferring and Rebiotix Present Positive Interim Phase 3 Results From Open-Label Study of…
Breadcrumb Trail Links PMN Press Releases Business Wire News Releases Author of the article:…
Read More...
Read More...
Metacrine to Present New Preclinical Data on MET642 in Inflammatory Bowel Disease at Digestive…
SAN DIEGO, May 19, 2021 (GLOBE NEWSWIRE) -- Metacrine, Inc. (NASDAQ:MTCR), a clinical-stage biopharmaceutical company…
Read More...
Read More...